Form 8-K · Current report
Procter & Gamble 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000080424
- Accession no.
- 0000080424-26-000093
Summary
The Procter & Gamble Company reported fiscal 2026 net sales of $87.0 billion, up 3%, and fourth-quarter net sales of $21.2 billion, up 2%, while fourth-quarter diluted EPS fell 15% to $1.26. The company guided fiscal 2027 organic sales growth of 1–3% and core EPS growth of in-line to 3%, and CEO Shailesh Jejurikar said fiscal 2026 was a year of foundation building amid a challenging environment.
Key points
- Procter & Gamble reported fiscal 2026 net sales of $87.0 billion, up 3%, and fourth-quarter net sales of $21.2 billion, up 2%.
- Fourth-quarter diluted EPS fell 15% to $1.26 and core EPS fell 3% to $1.43.
- P&G returned over $15 billion to shareholders in fiscal 2026, including $10.2 billion in dividends and $5.0 billion in share repurchases.
- P&G guided fiscal 2027 all-in sales growth of 1–3% and core EPS growth of in-line to 3%, equating to $6.89 to $7.11 per share.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 29, 2026, The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended June 30, 2026. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition." ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 29, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.